CoChat

Response to Total Sleep Deprivation Before and During Treatment with Fluvoxamine or Maprotiline in Patients with Major Depression - Results of a Double-Blind Study

Kasper, S., Voll, G., Vieira, A., Kick, H. · 1990 · Pharmacopsychiatry
Cited by 55

The DOI matches its Crossref record.

Abstract

To test the hypothesis that the antidepressant effects of total sleep deprivation (TSD) are linked to the serotonergic and/or noradrenergic system the authors carried out a double-blind study (fluvoxamine versus maprotiline) in 42 inpatients with endogenous depression (ICD). Patients were randomized to a four-week treatment with either fluvoxamine (100 - 300 mg/day) or maprotiline (100 - 300 mg/day). In addition, patients underwent a TSD procedure before and after one week of antidepressant medication. There was a statistically significant reduction of depression ratings (HDRS) in both the fluvoxamine and maprotiline group. The day-1 response to TSD before antidepressive medication was not associated with a clear relationship to the outcome after four weeks of treatment with either fluvoxamine or maprotiline. On the other hand, the day-2 response to TSD was significantly correlated with a good outcome to subchronic treatment with maprotiline. Furthermore, the results of the authors' data suggest that a favorable short-term outcome of TSD may be connected to antidepressants enhancing the serotonergic neurotransmission. The global comparison between fluvoxamine and maprotiline revealed that the group of patients treated with fluvoxamine had a significantly higher efficiency index (CGI) than the maprotiline group; fluvoxamine was rated to be tolerated excellently in 70 % of the patients whereas this percentage was only 43 % in the maprotiline group. There was also significantly more vertigo and dry mouth in the maprotiline group whereas the fluvoxamine group was rated to have significantly more sleep disturbances during the trial. Zusammenfassung Um zu untersuchen, ob der antidepressive Effekt des therapeutischen Schlafentzugs im Zusammenhang mit dem serotonergen und/oder noradrenergen System steht, haben wir eine doppelblinde Vergleichsstudie (Fluvoxamin versus Maprotilin) an 42 stationären, endogen depressiven Patienten durchgeführt. Entsprechend der Randomisierungsliste erhielten 21 Patienten das Medikament Fluvoxamin (100 - 300 mg/die) und 21 die Vergleichssubstanz Maprotilin (100 - 300 mg/die). Zusätzlich wurde vor und nach einwöchiger medikamentöser Therapie ein totaler Schlafentzug (TSD) durchgeführt. Die Patienten beider Medikamentengruppen zeigten im Behandlungszeitverlauf eine signifikante Abnahme in der Gesamtsumme der Hamilton Depressions Skala. Es konnte kein eindeutiger Zusammenhang zwischen der antidepressiven Reaktion am 1. Tag nach TSD (Tag-1 Response) und dem therapeutischen Ansprechen nach vierwöchiger Behandlung gefunden werden. Die antidepressive Reaktion am 2. Tag nach TSD (Tag-2 Response) stand hingegen in einem signifikanten Zusammenhang mit der späteren Ansprechbarkeit auf Maprotilin. Außerdem zeigte sich, daß durch die akute Gabe von Fluvoxamin der Rückfall am zweiten Tag nach TSD verhindert werden kann. Die Verträglichkeit des Medikamentes Fluvoxamin wurde in 70 % der Fälle als sehr gut beurteilt, während dies bei der Maprotilin-Gruppe nur in 43 % der Fälle angegeben wurde. Patienten in der Maprotilin-Gruppe wiesen signifikant häufiger Schwindel und Mundtrockenheit auf und in der mit Fluvoxamin behandelten Gruppe wurden signifikant häufiger Schlafstörungen registriert.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-2007-1014496

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 55

Metadata

Authors
Kasper, S., Voll, G., Vieira, A., & Kick, H.
Venue
Pharmacopsychiatry
Published
1990-05
Volume
23
Issue
03
Pages
135-142
ISSN
  • 0176-3679 (ISSN-L)
  • 1439-0795
OpenAlex
W2077970788
Cited by
55
References
0
FWCI
3.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Response to Total Sleep Deprivation Before and During Treatment with Fluvoxamine or Maprotiline in Patients with Major Depression - Results of a Double-Blind Study. https://app.cochat.ai/papers/10.1055/s-2007-1014496
The paper
Kasper, S., Voll, G., Vieira, A., & Kick, H. (1990). Response to Total Sleep Deprivation Before and During Treatment with Fluvoxamine or Maprotiline in Patients with Major Depression - Results of a Double-Blind Study. Pharmacopsychiatry. https://doi.org/10.1055/s-2007-1014496

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.